Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1977-06-27
1978-12-26
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
536 4, 536 17, A61K 3170, C07H 1524
Patent
active
041316495
ABSTRACT:
Daunorubicin (also known as daunomycin) derivatives of the formula ##STR1## wherein X is ##STR2## and R is --COCF.sub.3 or H which are prepared by hydrogenating 9-desacetyl-9-keto-N-trifluoroacetyldaunorubicin, an unexpectedly stable key-intermediate which is itself a new compound, are useful in treating certain mammalian tumors.
REFERENCES:
patent: 4020270 (1977-04-01), Arcamone et al.
patent: 4025623 (1977-05-01), Arcamone et al.
Angelucci Francesco
Arcamone Federico
Penco Sergio
Brown Johnnie R.
Societa Farmaceutici Italia S.p.A.
LandOfFree
Daunorubicin derivatives, their preparation and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Daunorubicin derivatives, their preparation and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Daunorubicin derivatives, their preparation and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1128471